DSpace Repository

New Zealand pharmaceutical management: analysis and prescription

Show simple item record

dc.contributor.author Barringer, Paul J
dc.date.accessioned 2011-09-12T21:21:13Z
dc.date.accessioned 2022-10-30T21:00:12Z
dc.date.available 2011-09-12T21:21:13Z
dc.date.available 2022-10-30T21:00:12Z
dc.date.copyright 1996
dc.date.issued 1996
dc.identifier.uri https://ir.wgtn.ac.nz/handle/123456789/26193
dc.description.abstract Public expenditure on pharmaceuticals in New Zealand has increased significantly in recent decades. Controlling the growth of pharmaceutical spending has been an important priority for health care policy makers, and both supply and demand side management initiatives have been implemented. The purpose of this thesis is to analyse and evaluate these New Zealand policy initiatives, based on a comparison of the New Zealand experience with that of other countries. Policy initiatives in a range of developed countries are evaluated with respect to the key criteria of equity and efficiency. Based on these international comparisons, potential modifications to New Zealand pharmaceutical policy are considered. Specifically, the thesis argues that New Zealand pharmaceutical policy can be improved through greater alignment of economic incentives, modified risk allocation, and integrated funding. en_NZ
dc.format pdf en_NZ
dc.language en_NZ
dc.language.iso en_NZ
dc.publisher Te Herenga Waka—Victoria University of Wellington en_NZ
dc.title New Zealand pharmaceutical management: analysis and prescription en_NZ
dc.type Text en_NZ
vuwschema.type.vuw Awarded Research Masters Thesis en_NZ
thesis.degree.discipline Commerce en_NZ
thesis.degree.grantor Te Herenga Waka—Victoria University of Wellington en_NZ
thesis.degree.level Masters en_NZ

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


My Account